NCT06374069

Brief Summary

The demographic life expectancy enhancement of the past 150 years imposes an urgent challenge in Western and economically growing societies to stimulate the healthy lifespan that is lagging behind. Families surviving into exceptionally high ages (longevity) in good physical and mental health illustrate that this is physiologically possible. Such families harbor cross generational socio-genetic mechanisms that mediate healthy aging and protection from (multi)morbidity. The purpose of our research is: to identify gene variants associated with healthy aging and protection from (multi)morbidity; to study the social-, environment- and behavioral factors of familial longevity, their role in (multi-)morbidity and its interaction with the genetic component.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Sep 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2023Dec 2026

Study Start

First participant enrolled

September 11, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 18, 2024

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 18, 2024

Status Verified

April 1, 2024

Enrollment Period

3.2 years

First QC Date

March 20, 2024

Last Update Submit

April 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identifying the genetic variants of Familial Longevity

    To identify gene variants associated with healthy aging and protection from (multi)morbidity

    through study completion, an average of 2 years

Secondary Outcomes (1)

  • Studying the environmental factor of Familial Longevity through questionnaires and its interaction with the genetic component

    through study completion, an average of 2 years

Study Arms (2)

Cases - Enriched for familial longevity

Siblings of dutch Caucasian descent ages 75 and older

Controls - Non-enriched for familial longevity

Individuals of dutch Caucasian descent ages 75 and older solely in their family.

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Dutch Caucasian descent: Ages 75 and older, with siblings enriched for familial longevity, and individuals without a history of familial longevity

You may qualify if:

  • Siblings of Dutch Caucasian descent age 75+ enriched for familial longevity
  • Individuals of Dutch Caucasian descent age 75+ who are not enriched for familial longevity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leiden University Medical Center

Leiden, South Holland, 2333ZA, Netherlands

RECRUITING

Central Study Contacts

(Eline) P. Slagboom, Prof. dr.

CONTACT

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Eline Slagboom, Prof. dr.

Study Record Dates

First Submitted

March 20, 2024

First Posted

April 18, 2024

Study Start

September 11, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 18, 2024

Record last verified: 2024-04

Locations